Acne vulgaris

Acne vulgaris is a common inflammatory skin disorder that primarily affects adolescents and young adults. It involves the pilosebaceous units and can significantly impact physical appearance and psychological well-being. Understanding its causes, mechanisms, and presentation is essential for effective management.

Introduction

Acne vulgaris is characterized by the presence of comedones, papules, pustules, nodules, and sometimes cysts. It is a multifactorial condition influenced by hormonal, microbial, genetic, and environmental factors. Acne can occur on the face, chest, back, and shoulders and may lead to scarring if not properly treated.

Globally, acne affects approximately 85% of adolescents and can persist into adulthood in some cases. It is not life-threatening but can have a profound impact on quality of life, self-esteem, and social interactions.

Etiology and Pathophysiology

Hormonal Factors

Androgens play a key role in acne development by increasing sebum production. Sebaceous glands become more active during puberty under hormonal influence. In females, fluctuations during menstrual cycles and pregnancy can exacerbate acne.

Microbial Factors

Cutibacterium acnes, a gram-positive bacterium, contributes to inflammation in acne lesions. It colonizes the pilosebaceous unit, leading to immune activation and cytokine release. An imbalance in the skin microbiota can further worsen the condition.

Genetic Predisposition

Family history is an important risk factor for acne. Certain genetic markers have been associated with increased sebaceous gland activity and inflammatory responses, making some individuals more susceptible.

Inflammatory Mechanisms

Acne lesions develop as a result of immune response to follicular obstruction and microbial colonization. Cytokines and other inflammatory mediators contribute to the formation of papules, pustules, and nodules. Hyperkeratinization of hair follicles leads to comedone formation, which is a hallmark of the disease.

Classification and Clinical Presentation

Types of Acne Lesions

• Comedonal acne: Characterized by open comedones (blackheads) and closed comedones (whiteheads) without significant inflammation.
• Inflammatory acne: Includes papules and pustules that appear red and swollen due to underlying inflammation.
• Nodulocystic acne: Severe form with large nodules and cysts that are painful and may lead to scarring.

Severity Grading

Acne severity can be classified into mild, moderate, and severe categories based on the type and number of lesions.

• Mild acne: Predominantly comedones with few inflammatory lesions.
• Moderate acne: Presence of numerous papules and pustules with some comedones.
• Severe acne: Extensive nodulocystic lesions, often leading to scarring and significant inflammation.

Distribution Patterns

Acne commonly affects areas rich in sebaceous glands:

• Face: Cheeks, forehead, chin, and jawline are most frequently involved.
• Trunk: Upper back and chest may develop lesions, especially in severe cases.
• Limbs: Less commonly affected but can occur in some individuals.

Risk Factors

• Hormonal influences: Puberty, menstrual cycles, pregnancy, and endocrine disorders can exacerbate acne.
• Dietary factors: High glycemic index foods, dairy products, and excessive sugar intake may contribute to lesion formation.
• Medications: Corticosteroids, lithium, anticonvulsants, and some oral contraceptives can trigger or worsen acne.
• Stress: Psychological stress can increase sebum production and inflammatory responses.
• Cosmetic and skincare products: Use of comedogenic products can block pores and promote acne development.

Diagnosis

Clinical Evaluation

The diagnosis of acne vulgaris is primarily clinical. A detailed history and thorough physical examination are essential to identify the type, severity, and distribution of lesions. Key aspects include:

• Age of onset and duration of acne
• Lesion types and patterns
• Family history of acne or related skin disorders
• Associated symptoms such as hyperandrogenism in females
• Previous treatments and response

It is also important to differentiate acne from other dermatological conditions such as rosacea, folliculitis, and keratosis pilaris.

Laboratory and Imaging Studies

Laboratory tests are generally not required for routine acne evaluation. However, specific tests may be indicated in certain situations:

• Hormonal assays (e.g., androgens, DHEAS, testosterone) in cases of severe or resistant acne in females
• Screening for underlying endocrine disorders such as polycystic ovary syndrome (PCOS)
• Imaging studies are rarely needed but may be considered if an underlying systemic disorder is suspected

Management

General Measures

Non-pharmacological strategies play an important role in managing acne:

• Gentle cleansing twice daily with non-comedogenic products
• Avoidance of excessive scrubbing or harsh skincare products
• Maintaining a healthy diet and hydration
• Reducing stress through lifestyle modifications and relaxation techniques
• Avoiding manipulation or picking of lesions to prevent scarring

Topical Therapies

Topical treatments are first-line therapy for mild to moderate acne:

• Retinoids: Normalize follicular keratinization and reduce comedone formation
• Benzoyl peroxide: Antimicrobial and anti-inflammatory effects; reduces C. acnes colonization
• Topical antibiotics: Clindamycin or erythromycin used in combination with benzoyl peroxide to minimize resistance
• Combination therapies are often more effective than monotherapy

Systemic Therapies

Systemic treatments are indicated for moderate to severe acne or cases resistant to topical therapy:

• Oral antibiotics: Doxycycline, minocycline, and erythromycin reduce inflammation and bacterial colonization.
• Hormonal therapy: Combined oral contraceptives and anti-androgens like spironolactone are effective in females with hormonally influenced acne.
• Isotretinoin: A potent oral retinoid for severe nodulocystic acne; requires careful monitoring due to potential teratogenicity and other side effects.

Adjunctive and Procedural Therapies

Procedural and adjunctive therapies can be used in combination with pharmacological treatments to enhance outcomes:

• Chemical peels to reduce comedones and superficial lesions
• Laser and light-based therapies targeting inflammation and sebum production
• Manual extraction of comedones by trained professionals
• Microneedling and other dermatological procedures for scar prevention and treatment

Complications

• Scarring: Atrophic, hypertrophic, and keloid scars may develop, especially in severe or untreated acne.
• Post-inflammatory hyperpigmentation: Dark spots or pigmentation changes often follow inflammatory lesions.
• Psychological impact: Acne can lead to anxiety, depression, and reduced self-esteem, affecting social and professional life.

Prevention and Prognosis

Early intervention and proper management are key to preventing complications of acne vulgaris. Regular follow-up and maintenance therapy help reduce relapse and minimize scarring.

• Adherence to prescribed topical or systemic therapy
• Use of non-comedogenic skincare and cosmetic products
• Healthy dietary habits with limited high glycemic index foods and dairy
• Stress management and adequate sleep
• Avoidance of lesion manipulation or picking

The prognosis of acne vulgaris is generally good with appropriate treatment. Mild cases may resolve spontaneously, while moderate to severe cases may require long-term management. Scarring risk is reduced with early and consistent therapy.

Recent Advances and Research

Recent research has focused on understanding the pathophysiology of acne and developing novel treatment approaches.

• Development of new topical formulations with improved efficacy and tolerability
• Exploration of microbiome modulation and probiotics for skin health
• Laser and light-based therapies targeting sebaceous glands and inflammation
• Investigation of targeted molecular therapies that reduce inflammation and sebum production
• Clinical trials evaluating combination therapies to enhance outcomes and minimize side effects

Ongoing research continues to improve individualized treatment strategies and prevent long-term complications.

References

1. James WD, Berger TG, Elston DM. Andrews’ Diseases of the Skin: Clinical Dermatology. 14th ed. Philadelphia: Elsevier; 2021.
2. Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.e33.
3. Kurokawa I, Danby FW, Ju Q, Wang X, Xiang LF, Xia L, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18(10):821-832.
4. Layton AM. The use of isotretinoin in acne. Dermatoendocrinol. 2009;1(3):162-169.
5. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474-485.
6. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-S37.
7. Thiboutot D, Layton AM. Acne vulgaris. N Engl J Med. 2007;356:971-979.
8. Cunliffe WJ, van de Kerkhof PCM, Capitanio B, Dreno B. Acne. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s Textbook of Dermatology. 9th ed. Wiley-Blackwell; 2016. p. 45.1-45.62.